Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,150,000 | 3,693,000 | 2,746,000 | 3,523,000 | 4,074,000 |
| Marketable Securities | 9,000 | 21,000 | 2,246,000 | 4,154,000 | 61,000 |
| Inventories | 5,924,000 | 5,669,000 | 5,498,000 | 5,146,000 | 5,783,000 |
| Other current assets | 8,042,000 | 7,224,000 | 7,799,000 | 7,603,000 | 8,441,000 |
| TOTAL | $17,510,000 | $16,997,000 | $18,644,000 | $20,769,000 | $18,674,000 |
| Non-Current Assets | |||||
| PPE Net | 10,048,000 | 10,073,000 | 9,957,000 | 9,620,000 | 10,672,000 |
| Intangibles | 23,766,000 | 22,497,000 | 21,579,000 | 21,364,000 | 40,631,000 |
| Other Non-Current Assets | 9,794,000 | 9,896,000 | 8,825,000 | 8,393,000 | 9,126,000 |
| TOTAL | $43,608,000 | $42,466,000 | $40,361,000 | $39,377,000 | $60,429,000 |
| Total Assets | $61,118,000 | $59,463,000 | $59,005,000 | $60,146,000 | $79,103,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,875,000 | 2,181,000 | 2,657,000 | 3,785,000 | 3,398,000 |
| Accounts payable and accrued liabilities | 3,535,000 | 3,462,000 | 3,717,000 | 3,866,000 | 4,535,000 |
| Other current liabilities | 1,348,000 | 1,172,000 | 1,053,000 | 1,289,000 | 958,000 |
| TOTAL | $21,391,000 | $21,697,000 | $21,068,000 | $22,810,000 | $23,670,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,015,000 | 13,703,000 | 14,154,000 | 16,194,000 | 19,760,000 |
| Other Non-Current Liabilities | 9,072,000 | 10,081,000 | 9,924,000 | 10,335,000 | 3,591,000 |
| TOTAL | $23,771,000 | $24,680,000 | $25,142,000 | $27,240,000 | $34,091,000 |
| Total Liabilities | $45,162,000 | $46,377,000 | $46,210,000 | $50,050,000 | $57,761,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,349,000 | 1,348,000 | 1,348,000 | 1,347,000 | 1,347,000 |
| Retained earnings | 10,209,000 | 7,796,000 | 7,239,000 | 4,363,000 | 7,944,000 |
| Other shareholders' equity | 1,321,000 | 1,054,000 | 1,309,000 | 1,448,000 | 2,463,000 |
| TOTAL | $16,377,000 | $13,671,000 | $13,347,000 | $10,598,000 | $15,055,000 |
| Total Liabilities And Equity | $61,539,000 | $60,048,000 | $59,557,000 | $60,648,000 | $72,816,000 |